#PhalconBio
🦠 #INCATE, co-founded by #DZIF, awards Swiss start-up #PhalconBio €250,000 to advance preclinical development of an inhaled phage therapy for ventilator-associated pneumonia.

👉 Read more: t1p.de/0agp5

#AMR #PhageTherapy @incate.bsky.social
INCATE awards PhalconBio Stage II Funding to advance Dual-Action Phages for severe bacterial pneumonia | German Center for Infection Research
The Incubator for Antimicrobial Therapies in Europe, INCATE, aims to support innovators in the early stages of developing therapies in the field of
t1p.de
October 8, 2026 at 7:30 AM
The INCATE family keeps on growing!
Our Selection Committee has selected 4 new ventures for Stage I support:

- Arvalus Therapeutics
- mycoBiologics Ltd
- PhalconBio
- Alterbiotix

Find more ➡ www.incate.net/4-new-additi...
and take a look at our portfolio ➡ lnkd.in/e_3fns8x
4 new additions to our portfolio! - INCATE
The INCATE Selection Committee selected the new 4 ventures for Stage I support. Meet the new additions to the INCATE family:Arvalus Therapeutics - Arvalus is pioneering a next-generation live biothera...
www.incate.net
February 18, 2025 at 8:22 AM